research

A federal judge has ruled that the Trump administration's decision to cancel more than $1 billion in research grants from the National Institutes of Health (NIH) was unlawful. The move, disproportionately impacting diversity-related studies, was challenged by states, academic institutions and civil...

When engaging in initial conversations with new acquaintances, don't be so quick to list one's job title, education, and accomplishments. Research suggests that this approach may not be as effective as previously thought. According to CNBC, citing a Harvard and Wharton study, students were...

A study funded by the U.S. National Institutes of Health (NIH) and Canadian Institutes of Health Research (CIHR), found that cannabis is associated with reduced opioid cravings for people using unregulated opioids (PWUO) and people living with chronic pain.  Researchers at the ...

Tom Vilsack, US Department of Agriculture (USDA) Secretary, announced that the agency would invest more than $146 million in sustainable agricultural research projects, of which $20 million will be earmarked for hemp projects. The investment, made under the National...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Cybin (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional...

AnaptysBio Inc’s (NASDAQ: ANAB) stock seems attractive after the POPLAR data and the 30% selloff, while there are several catalysts over the next 12-18 months, according to Truist Securities. AnaptysBio is a clinical-stage biotechnology company developing first-in-class immunology...

Moderna, Inc. (NASDAQ: MRNA), which shot to prominence with its coronavirus vaccine program, is beefing up its research and development team. What Happened: Jonathan Hoggatt, who was a principal faculty member at Harvard Stem Cell Institute, has joined Cambridge, Massachusetts-based Moderna...

Financial Markets across several African countries have seen significant improvements in the year 2018-19, says research conducted by OMFIF (Official Monetary and Financial Institutions Forum) and pan-African financial group Absa. What Happened OMFIF measures the countries’ financial markets...

A biotech with licensing agreements with some of the big-name pharma companies such as AbbVie Inc (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ)'s Janssen unit is testing the IPO waters this week. IPO Terms Waltham, Massachusetts-based Morphic Holding is offering 5 million shares in an IPO...

A lot of news has been circulating in regards to stocks that could benefit from the recent Ebola virus outbreak. Although investors might want to proceed with caution when it comes to these news-driven biotech stocks, it never hurts to review the landscape for potential opportunities. Related...